Skip to content

The effect of intraoperative intravenous injection of lidocaine on postoperative sleep quality in patients undergoing thyroidectomy: a multicenter randomized controlled study

The effect of intraoperative intravenous injection of lidocaine on postoperative sleep quality in patients undergoing thyroidectomy: a multicenter randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099128
Enrollment
Unknown
Registered
2025-03-19
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep quality on patients undergoing thyroidectomy surgery

Interventions

Control group (D group):Intravenous injection of normal saline
Lidocaine group (L group):Intravenous injection of lidocaine

Sponsors

First Hospital Of Nanping
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.The American Society of Anesthesiologists (ASA) grades I-II; 2.Age range: 18-65 years old; 3.Body Mass Index (BMI) 18.5-30 kg/m^2; 4.Selective thyroidectomy under general anesthesia; 5.Can understand the content of the assessment scale and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. The patient refused the trial; 2. Patients allergic to lidocaine; 3. Long term use of sleep aids, steroid drugs, or abuse of alcohol and drugs; 4. Individuals with chronic diseases such as hypertension and severe liver, liver, and kidney diseases; 5. Individuals with severe mental illnesses; 6. Merge neurological disorders; 7. Individuals with a history of major surgery within 6 months prior to surgery; 8. Individuals with severe conduction block.

Design outcomes

Primary

MeasureTime frame
Subjective sleep quality;Objective sleep quality;

Secondary

MeasureTime frame
blood serum;Postoperative pain score;

Countries

China

Contacts

Public ContactZhangren Chen

First Hospital Of Nanping

37566794@qq.com+86 138 5098 0376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026